Oncode Oncology Bridge Fund
Overview
The Oncode Oncology Bridge Fund is a venture capital fund established by Oncode Institute to support the creation and development of new enterprises based on innovative cancer research. The fund provides pre-seed and seed financing to commercially viable enterprises, aiming to accelerate the translation of research ideas into market-ready solutions that benefit patients and society. Managed by Oncode B.V., a wholly owned subsidiary of Oncode Institute, the fund is overseen by a Supervisory Board that monitors its overall strategy and operations. The fund primarily invests in companies founded by Oncode Institute researchers or those developing Oncode technologies, focusing on oncology. Investment criteria include a commercially viable business case, a clear go-to-market strategy, and a viable business plan detailing products, markets, and profitability. The fund also welcomes co-investments from industry and venture partners to further support the growth of these enterprises. Since its inception, the Oncode Oncology Bridge Fund has supported several companies, including Flindr Therapeutics, which raised €20 million in a Series A financing round in April 2024. This investment underscores the fund's commitment to advancing innovative cancer therapies and its role in bridging the gap between research and commercialization.
Investment Focus
- Founded by Oncode Institute researchers
- Developing Oncode technologies
- Operating within the field of oncology
- Commercially viable business case
- Clear go-to-market strategy
- Viable business plan detailing products, markets, and profitability
Portfolio Companies
Get the full list of 54,000+ investors
Oncode Oncology Bridge Fund and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Oncode Oncology Bridge Fund
What sectors does Oncode Oncology Bridge Fund invest in?
Oncode Oncology Bridge Fund invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in Netherlands. Oncode Oncology Bridge Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does Oncode Oncology Bridge Fund invest at?
Oncode Oncology Bridge Fund backs companies at Pre-Seed and Seed.
Which regions does Oncode Oncology Bridge Fund invest in?
Oncode Oncology Bridge Fund invests across Netherlands.
What companies has Oncode Oncology Bridge Fund invested in?
Oncode Oncology Bridge Fund's portfolio includes Flindr Therapeutics, Cyclomics, Laigo Bio, Oncosence, Single Cell Discoveries, Simmunext Biotherapeutics and Cell Control.
Last updated · Source: ConnectSafely investor database